Clinical manifestations, complications and treatment of brucellosis: 45 patients study;Aspects cliniques, microbiologiques et thérapeutiques de la brucellose : étude de 45 cas

Pathologie Biologie

Volumn 57, Issue 5, 2009, Pages 349-352

  Zribi, M ^a   Ammari, L ^a   Masmoudi, A ^a   Tiouiri, H ^a   Fendri, C ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Brucellosis; Clinical features; Diagnosis; Epidemiology; Treatment

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TEST; ANEMIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRALGIA; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; DEATH; DIAGNOSTIC PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; LABORATORY TEST; LEUKOPENIA; MALE; NONHUMAN; SEROLOGY; SPLENOMEGALY; SWEATING; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BACTEREMIA; BRUCELLA ABORTUS; BRUCELLOSIS; DAIRY PRODUCTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOOD MICROBIOLOGY; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; RETROSPECTIVE STUDIES; RIBOTYPING; SPLENOMEGALY; TUNISIA; YOUNG ADULT;

EID: 67649228163     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.02.003     Document Type: Article

References (17)

1. Seimensis A., Morelli D., and Mantovani A. Zoonoses in the Mediterranean region. Ann Ist Super Sanita 42 4 (2006) 437-445
2. Brown S.D., Traczewski M.M., and The Brucella QC Working Group. Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains. J Clin Microbiol. 43 11 (2005) 5804-5807
3. ème siècle. Med Mal Infect 35 (2005) 6-16
4. Refai M. Incidence and control of brucellosis in the Near-East region. Vet Microbiol 90 (2002) 81-110
5. Basappa G, Mallanagouda S, Rajendra C, Mallana S, VeerappaK, Piarayla K, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 year's experience in an endemic area. J Med Microbiol 2006;55:897-903.
6. Queipo-Ortuno M.I., Morata P., Ocon P., Manchado P., and Colmenero J.D. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol 35 (1997) 2927-2930
7. Garin-Bastuji B, Delcueillerie F. Les brucelloses humaine et animale en France en l'an 2000. Situation épidémiologique - Programmes de contrôle et d'éradication. Med Mal Infect 2001; 31(suppl 2):202-6.
8. Young E.J. Brucellosis: an overview. Emerg Infect Dis 21 (1995) 283-290
9. Trujillo I.Z., Zavala A.N., Caceres J.G., and Miranda C.Q. Brucellosis. Infect Dis Clin North Am 8 (1994) 225-241
10. Solera J., Martinez-Alfaro E., and Espinosa A. Recognition and optimum treatment of brucellosis. Drugs 53 (1997) 245-256
11. Solera J., Lozano E., Martinez-Alfaro E., Espinosa A., Castillejos M.L., and Abad L. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 29 (1999) 1440-1449
12. Ariza J., Pujol M., Valverde J., Nolla J.M., Rufi G., Viladrich P.F., et al. Brucellar sacroiliitis: findings in 63 episodes and current relevance. Clin Infect Dis 16 (1993) 761-765
13. Reguera J.M., Alarcon A., Miralles F., Pachon J., Juarez C., and Colmenero J.D. Brucella endocarditis: clinical, diagnosic, and therapeutic approach. Eur J Microbil Infect Dis 22 (2003) 647-650
14. Basappa G., Mantur, and Smita Mangalgi S. Evaluation of conventional castenada and lysis centrifugation blood culture techniques for dianosis of human brucellosis. J Clin Microbiol 42 (2004) 4327-4328
15. Turkmani A., Ioannidis A., Christidou A., Psaroulaki, Loukaides, and Tselentis Y. In vitro succeptibilities of Brucella melitensis isolates to eleven antibiotics. Ann Clin Microbiol 5 (2006) 1-4
16. Baykam N., Esener H., Ergonul O., Eren S., Celikbas A.K., and Dokuzoguz B. In vitro antimicrobial succebtibility ob Brucelle species. Intern J Antimicrob Agents 23 (2004) 405-407
17. Aygen B., Doganay M., Sumerkan B., Yildiz O., and Kayabas U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect 32 (2002) 485-493